Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT02728934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparative and Pragmatic Study of Simponi Aria Versus Remicade in Rheumatoid Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the proportion of patients with an infusion reaction in Rheumatoid arthritis (RA) patients treated with Golimumab Intravenous (IV) or Infliximab.
Study identification
- NCT ID
- NCT02728934
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,279 participants
Conditions and interventions
Conditions
Interventions
- Golimumab Intravenous (IV) Biological
- Infliximab Biological
- Biosimilar Infliximab Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 25, 2016 (Actual)
- Primary completion
- Jan 31, 2020 (Actual)
- Completion
- Jan 31, 2020 (Actual)
- Last update posted
- Apr 15, 2020
2016 – 2020
United States locations
- U.S. sites
- 85
- U.S. states
- 27
- U.S. cities
- 85
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Glendale | Arizona | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Peoria | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Prescott | Arizona | — | — |
| Not listed | Sun City | Arizona | — | — |
| Not listed | Bakersfield | California | — | — |
| Not listed | Campbell | California | — | — |
| Not listed | Covina | California | — | — |
| Not listed | El Cajon | California | — | — |
| Not listed | Hemet | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Santa Cruz | California | — | — |
| Not listed | Thousand Oaks | California | — | — |
| Not listed | Upland | California | — | — |
| Not listed | Van Nuys | California | — | — |
| Not listed | West Hills | California | — | — |
| Not listed | Whittier | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Lakewood | Colorado | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Palm Harbor | Florida | — | — |
| Not listed | Plantation | Florida | — | — |
| Not listed | Tamarac | Florida | — | — |
| Not listed | Venice | Florida | — | — |
| Not listed | Lawrenceville | Georgia | — | — |
| Not listed | Springfield | Illinois | — | — |
| Not listed | Muncie | Indiana | — | — |
| Not listed | Bowling Green | Kentucky | — | — |
| Not listed | Baton Rouge | Louisiana | — | — |
| Not listed | Monroe | Louisiana | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Cumberland | Maryland | — | — |
| Not listed | Hagerstown | Maryland | — | — |
| Not listed | Towson | Maryland | — | — |
| Not listed | Wheaton | Maryland | — | — |
| Not listed | Ann Arbor | Michigan | — | — |
| Not listed | Lansing | Michigan | — | — |
| Not listed | Saint Clair Shores | Michigan | — | — |
| Not listed | Eagan | Minnesota | — | — |
| Not listed | Edina | Minnesota | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Nashua | New Hampshire | — | — |
| Not listed | Freehold | New Jersey | — | — |
| Not listed | Voorhees Township | New Jersey | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Orchard Park | New York | — | — |
| Not listed | Greensboro | North Carolina | — | — |
| Not listed | Leland | North Carolina | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Edmond | Oklahoma | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Bethlehem | Pennsylvania | — | — |
| Not listed | Duncansville | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Wexford | Pennsylvania | — | — |
| Not listed | Myrtle Beach | South Carolina | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Amarillo | Texas | — | — |
| Not listed | Beaumont | Texas | — | — |
| Not listed | College Station | Texas | — | — |
| Not listed | Corpus Christi | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Lubbock | Texas | — | — |
| Not listed | Mesquite | Texas | — | — |
| Not listed | Nassau Bay | Texas | — | — |
| Not listed | Plano | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | San Marcos | Texas | — | — |
| Not listed | Sugar Land | Texas | — | — |
| Not listed | The Woodlands | Texas | — | — |
| Not listed | Waco | Texas | — | — |
| Not listed | Arlington | Virginia | — | — |
| Not listed | Chesapeake | Virginia | — | — |
| Not listed | Newport News | Virginia | — | — |
| Not listed | Kennewick | Washington | — | — |
| Not listed | Seattle | Washington | — | — |
| Not listed | Beckley | West Virginia | — | — |
| Not listed | South Charleston | West Virginia | — | — |
| Not listed | Glendale | Wisconsin | — | — |
| Not listed | Onalaska | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02728934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2020 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02728934 live on ClinicalTrials.gov.